MILNER THERAPEUTICS SYMPOSIUM 2021
Tuesday 22nd June, Online
Milner Therapeutics Symposium 2021
Symposium Overview
Thank you for attending the 2021 Milner Therapeutics Symposium.
If you have questions relating to this event, or if you’d like to join our email list to receive information
about future events, please email events@milner.cam.ac.uk.
This one-day online event was an opportunity for scientists from academia and industry to discuss their latest research and its potential to be applied in pharma and biotech towards new treatments.
PROGRAMME »
Themes
Oncology · CNS therapeutics · Microbiome · Emerging technologies · Disease-relevant models in target discovery
Speakers
David Liu (Harvard) · Jeff Settleman (Pfizer) · Charles Swanton (The Francis Crick Institute and Achilles Therapeutics) · Nevan Krogan (UCSF) · Fiona Menzies (Eli Lilly and Company) · Virginia Pedicord (Cambridge Institute of Therapeutic Immunology and Infectious Disease) · Kostas Tzelepis (Milner Therapeutics Institute) · Marcel Gehrung (Cyted) · Joo-Hyeon Lee (Wellcome MRC Cambridge Stem Cell Institute)
You can find out more about our speakers further down this page.
Speakers & Sessions
Charles Swanton
The Francis Crick Institute and Achilles Therapeutics
Marcel Gehrung
Cyted
Fiona Menzies
Eli Lilly and Company
David Liu
Harvard
Kostas Tzelepis
Milner Therapeutics Institute
Virginia Pedicord
Cambridge Institute of Therapeutic Immunology and Infectious Disease (CITIID)
Jeff Settleman
Pfizer
Joo-Hyeon Lee
Wellcome MRC Cambridge Stem Cell Institute
Panel Session: The Cambridge cluster: now and the future
Session 1: Cambridge and business … How can we work together?
Tony Kouzarides
Director, Milner Therapeutics Institute
Ian Tomlinson
Chair, Apollo Therapeutics and Start Codon
Alan Hirzel
CEO, Abcam
Derek Jones
Director, Babraham Research Campus
Jason Mellad
CEO, Start Codon
Susan Galbraith
Senior Vice President and Head of Research and Early Development, Oncology R&D
AstraZeneca
Session 2: Cambridge and business… how can we deliver?
Tony Kouzarides
Director, Milner Therapeutics Institute
Ian Tomlinson
Chair, Apollo Therapeutics and Start Codon
Harriet Fear
Director, Cambridge&
Mark Welland
Director, Maxwell Centre
Kathryn Chapman
Deputy Director, Milner Therapeutics Institute
Andy Neely
Pro-Vice-Chancellor for Enterprise and Business Relations
University of Cambridge